AB1-SSA1-SA2,190,1911 49.45 (21) (a) Before a person may take over the operation of a provider that
12is
If any provider liable for repayment of improper or erroneous payments or
13overpayments under ss. 49.43 to 49.497, full repayment shall be made. Upon
14request, the department shall notify the provider or the person that intends to take
15over the operation of the provider as to whether the provider
sells or otherwise
16transfers ownership of his or her business or all or substantially all of the assets of
17the business, the transferor and transferee are each liable for the repayment. Prior
18to final transfer, the transferee is responsible for contacting the department and
19ascertaining if the transferor
is liable under this paragraph.
AB1-SSA1-SA2, s. 121px 20Section 121px. 49.45 (21) (b) of the statutes, as affected by 2001 Wisconsin Act
2116
, is amended to read:
AB1-SSA1-SA2,191,622 49.45 (21) (b) If, notwithstanding the prohibition under par. (ar), a person takes
23over the operation of a provider
If a transfer occurs and the applicable amount under
24par. (ar) (a) has not been repaid, the department may, in addition to withholding
25certification as authorized under sub. (2) (b) 8.,
proceed against the provider or the

1person
either the transferor or the transferee. Within 30 days after the certified
2provider receives
receiving notice from the department, the transferor or the
3transferee shall pay the
amount shall be repaid in full. If the amount is not repaid
4in full
Upon failure to comply, the department may bring an action to compel
5payment,. If a transferor fails to pay within 90 days after receiving notice from the
6department, the department
may proceed under sub. (2) (a) 12., or may do both.
AB1-SSA1-SA2, s. 121py 7Section 121py. 49.45 (21) (e) of the statutes, as created by 2001 Wisconsin Act
816
, is repealed.".
AB1-SSA1-SA2,191,10 9159. Page 38, line 21: delete the material beginning with that line and ending
10with page 39, line 10, and substitute:
AB1-SSA1-SA2,191,11 11" Section 122b. 49.45 (49) of the statutes is created to read:
AB1-SSA1-SA2,191,1212 49.45 (49) Prescription drug prior authorization. (a) In this subsection:
AB1-SSA1-SA2,191,1413 1. "Average manufacturer price" has the meaning given in 42 USC 1396r-8 (k)
14(1).
AB1-SSA1-SA2,191,1515 2. "HIV infection" has the meaning given in s. 252.01 (2).
AB1-SSA1-SA2,191,1616 3. "Institution for mental diseases" has the meaning given in s. 46.011 (1m).
AB1-SSA1-SA2,191,1817 4. "Intermediate care facility for the mentally retarded" has the meaning given
18in s. 46.278 (1m) (am).
AB1-SSA1-SA2,191,1919 5. "Nursing home" has the meaning given in s. 50.01 (3).
AB1-SSA1-SA2,191,2020 6. "Pharmacist" has the meaning given in s. 450.01 (15).
AB1-SSA1-SA2,191,2121 7. "Physician" has the meaning given in s. 448.01 (5).
AB1-SSA1-SA2,191,2322 8. "Preferred prescription drug list" means a list of prescription drugs to which
23prior authorization does not apply.
AB1-SSA1-SA2,191,2424 9. "Prescription drug" has the meaning given in s. 450.01 (20).
AB1-SSA1-SA2,192,3
1(b) Except for all of the following, beginning July 1, 2003, the department shall
2subject all prescription drugs that are prescribed for medical assistance recipients
3to requirements of prior authorization:
AB1-SSA1-SA2,192,54 1. Prescription drugs that are used to treat mental illness, including anxiety,
5depression, or psychosis, or to treat HIV infection.
AB1-SSA1-SA2,192,86 2. Prescription drugs that are prescribed for residents of nursing homes, of
7institutions for mental diseases, and of intermediate care facilities for the mentally
8retarded.
AB1-SSA1-SA2,192,109 3. Prescription drugs that are included in a preferred prescription drug list of
10the department under par. (f).
AB1-SSA1-SA2,192,1311 (c) The secretary shall exercise his or her authority under s. 15.04 (1) (c) to
12create a prescription drug prior authorization committee and shall appoint as
13members at least all of the following:
AB1-SSA1-SA2,192,1414 1. Two physicians who are currently in practice.
AB1-SSA1-SA2,192,1515 2. Two pharmacists.
AB1-SSA1-SA2,192,1816 3. One advocate for recipients of medical assistance who has sufficient medical
17background, as determined by the department, to evaluate a prescription drug's
18clinical effectiveness.
AB1-SSA1-SA2,192,2019 (d) The prescription drug prior authorization committee appointed under par.
20(c) shall do all of the following:
AB1-SSA1-SA2,192,2521 1. Review the department's prior authorization policies and advise the
22department on issues related to prior authorization decisions made concerning
23prescription drugs on behalf of medical assistance recipients. In making its review
24under this subdivision, the committee shall accept information or commentary from
25representatives of the pharmaceutical manufacturing industry.
AB1-SSA1-SA2,193,4
12. Consider the clinical efficacy, safety, and cost effectiveness of prescription
2drugs and develop and provide to the department a recommended preferred
3prescription drug list. In initially developing and subsequently revising the
4preferred prescription drug list, the committee shall do all of the following:
AB1-SSA1-SA2,193,75 a. Ensure that the manufacturers of prescription drugs that agree to provide
6a supplemental rebate, as specified in par. (h), have an opportunity to present
7evidence supporting inclusion of a product on the list.
AB1-SSA1-SA2,193,98 b. At least every 12 months, review all prescription drug classes included in the
9department's list of preferred prescription drugs under par. (f).
AB1-SSA1-SA2,193,1210 c. From the department's list of preferred prescription drugs under par. (f),
11recommend additions or deletions that permit cost-saving, medically appropriate
12drug therapies for medical assistance recipients.
AB1-SSA1-SA2,193,1413 (e) The department shall do all of the following on behalf of the prescription
14drug prior authorization committee:
AB1-SSA1-SA2,193,1815 1. If the department has received timely notice that a drug or any of its uses
16has received approval by the federal food and drug administration under a priority
17new drug application, ensure that the drug will be reviewed by the committee at the
18committee's earliest regularly scheduled meeting.
AB1-SSA1-SA2,193,2119 2. If the department has received notice from a drug manufacturer of a new
20drug product, schedule, to the extent possible, a product review for the product by
21the committee at the committee's earliest regularly scheduled meeting.
AB1-SSA1-SA2,193,2422 (f) 1. After considering all of the following, the department may, beginning July
231, 2002, adopt a preferred prescription drug list and shall disseminate the list to all
24appropriate providers of medical assistance:
AB1-SSA1-SA2,194,2
1a. The recommendation of the prescription drug prior authorization committee
2under par. (d) 2.
AB1-SSA1-SA2,194,33 b. The clinical efficacy of a prescription drug.
AB1-SSA1-SA2,194,54 c. The price of competing products minus payment of any rebate made under
542 USC 1396r-8 and par. (h).
AB1-SSA1-SA2,194,66 d. If par. (h) 4. applies.
AB1-SSA1-SA2,194,107 2. The department shall periodically update the preferred prescription drug
8list, based on the department's consideration of recommendations of the prescription
9drug prior authorization committee and shall disseminate the changes to
10appropriate providers.
AB1-SSA1-SA2,194,1211 3. The department shall make the preferred prescription drug list under subd.
121. and the updates under subd. 2. publicly available.
AB1-SSA1-SA2,194,1813 (g) A medical assistance recipient may contest the decision of the department
14to deny prior authorization for a prescription drug that is excluded from the
15preferred prescription drug list under par. (f) by filing, within 45 days after denial
16of coverage for a prescription drug that is subject to prior authorization, a written
17request for a hearing under s. 227.44 to the division of hearings and appeals created
18under s. 15.103 (1).
AB1-SSA1-SA2,194,2019(h) 1. If a manufacturer of a prescription drug pays a rebate under 42 USC
201396r-8
, one of the following applies:
AB1-SSA1-SA2,195,221 a. If the rebate is less than 15.1%, the department may enter into an
22arrangement with the manufacturer that requires the manufacturer to provide a
23supplemental rebate to the department in an amount that, together with the rebate
24paid under 42 USC 1396r-8, equals at least 15.1% of the average manufacturer price
25for the manufacturer's prescription drug products that are provided to medical

1assistance recipients, except that the department may determine that a specific
2prescription drug is competitive at a lower rebate percentage.
AB1-SSA1-SA2,195,93 b. If the rebate is at least 15.1%, the department may enter into an
4arrangement with the manufacturer that requires the manufacturer to provide a
5supplemental rebate to the department in an amount that, together with the rebate
6paid under 42 USC 1396r-8, equals at least 25.1% of the average manufacturer price
7for the manufacturer's prescription drug products that are provided to medical
8assistance recipients, except that the department may determine that a specific
9prescription drug is competitive at a lower rebate percentage.
AB1-SSA1-SA2,195,1110 2. Payment of rebates under subd. 1. shall be used to offset expenditures under
11s. 20.435 (4) (b), (bc), (bv), (o), and (p).
AB1-SSA1-SA2,195,1912 3. The supplemental rebate under subd. 1. a. or b. may include, at the discretion
13of the department, a program benefit that offsets a medical assistance cost, including
14a disease management program, a drug product donation program, a drug utilization
15control program, a program of prescriber and beneficiary counseling and education,
16or a program to reduce medical assistance fraud and abuse, or may include a cash
17rebate. The department may request from the federal secretary of health and human
18services a waiver of federal medicaid laws necessary to permit the department of
19health and family services to implement this subdivision.
AB1-SSA1-SA2,195,2320 4. If a manufacturer of prescription drugs agrees to pay the minimum
21supplemental rebate rate under subd. 1. a. or b., the department shall consider
22including a prescription drug of the manufacturer in the preferred prescription drug
23list under par. (f).
AB1-SSA1-SA2,196,924 (i) Trade secrets, amounts of rebates or supplemental rebates, percentages of
25rebate rates, and pricing of prescription drugs by prescription drug manufacturers

1that are contained in records of the department or the department's agent with
2respect to a supplemental rebate negotiation or supplemental rebate agreement
3under par. (h) 1. are not public records under subch. II of ch. 19 and shall be kept
4confidential in accordance with 42 USC 1396r-8 (b) (3) (D). Those portions of
5meetings of the prior authorization prescription drug advisory committee at which
6trade secrets, amounts of rebates or supplemental rebates, percentages of rebate
7rates, and pricing of prescription drugs by prescription drug manufacturers are not
8subject to subch. V of ch. 19 and shall be kept confidential in accordance with 42 USC
91396r-8
(b) (3) (D).
AB1-SSA1-SA2,196,1110 (j) The department may enter into a contract with an entity to perform the
11duties and exercise the powers of the department under pars. (h) 1. a. and b.
AB1-SSA1-SA2,196,1712 (k) Annually, by January 15, the department shall submit to appropriate
13standing committees of the legislature under s. 13.172 (3) and to the governor a
14report on the implementation of the department of the program under this
15subsection, including any progress made in implementing cost-containment
16measures under medical assistance and its effect on expenditures under medical
17assistance for prescription drugs.
AB1-SSA1-SA2, s. 122c 18Section 122c. 49.45 (50) of the statutes is created to read:
AB1-SSA1-SA2,196,2419 49.45 (50) Right to appeal prescription drug coverage decision. The
20department shall inform each medical assistance recipient of his or her right, under
21sub. (49) (g), to contest a decision by the department to deny prior authorization for
22a prescription drug that is excluded from the preferred prescription drug list under
23sub. (49) (f), if the decision results in denial of coverage to the recipient for the
24prescription drug.".
AB1-SSA1-SA2,197,1
1160. Page 46, line 20: after that line insert:
AB1-SSA1-SA2,197,3 2" Section 145g. 49.85 (2) (a) of the statutes, as affected by 2001 Wisconsin Act
316
, is amended to read:
AB1-SSA1-SA2,197,114 49.85 (2) (a) At least annually, the department of health and family services
5shall certify to the department of revenue the amounts that, based on the
6notifications received under sub. (1) and on other information received by the
7department of health and family services, the department of health and family
8services has determined that it may recover under s. 49.45 (2) (a) 10. or 49.497, except
9that the department of health and family services may not certify an amount under
10this subsection unless it has met the notice requirements under sub. (3) and unless
11its determination has either not been appealed or is no longer under appeal.
AB1-SSA1-SA2, s. 145h 12Section 145h. 49.85 (3) (a) 1. of the statutes, as affected by 2001 Wisconsin Act
1316
, is amended to read:
AB1-SSA1-SA2,197,1714 49.85 (3) (a) 1. Inform the person that the department of health and family
15services intends to certify to the department of revenue an amount that the
16department of health and family services has determined to be due under s. 49.45
17(2) (a) 10. or
49.497, for setoff from any state tax refund that may be due the person.".
AB1-SSA1-SA2,197,18 18161. Page 47, line 25: after that line insert:
AB1-SSA1-SA2,197,19 19" Section 148f. 50.375 of the statutes is created to read:
AB1-SSA1-SA2,197,21 2050.375 Emergency contraception for alleged victims of sexual assault.
21(1) In this section:
AB1-SSA1-SA2,198,422 (a) "Emergency contraception" means a drug, medicine, oral hormonal
23compound, mixture, preparation, instrument, article, or device that is approved by
24the federal food and drug administration that prevents a pregnancy after sexual

1intercourse. "Emergency contraception" does not include a drug, medicine, oral
2hormonal compound, mixture, preparation, instrument, article, or device of any
3nature that is prescribed to terminate the pregnancy of a woman who is known by
4the prescribing licensed health care provider to be pregnant.
AB1-SSA1-SA2,198,55 (b) "Sexual assault" means a violation of s. 940.225 (1), (2), or (3).
AB1-SSA1-SA2,198,7 6(2) A hospital that provides emergency services to an alleged victim of sexual
7assault shall, after obtaining the consent of the victim, do all of the following:
AB1-SSA1-SA2,198,98 (a) Provide to the victim medically and factually accurate and unbiased written
9and oral information about emergency contraception.
AB1-SSA1-SA2,198,1110 (b) Orally inform the victim of her option to receive emergency contraception
11at the hospital.
AB1-SSA1-SA2,198,1312 (c) Provide emergency contraception immediately at the hospital to the victim
13if she requests it.
AB1-SSA1-SA2,198,17 14(3) A hospital that provides emergency care shall ensure that each hospital
15employee who provides care to an alleged victim of sexual assault has available
16medically and factually accurate and unbiased information about emergency
17contraception.
AB1-SSA1-SA2,198,21 18(4) The department shall respond to any complaint received by the department
19concerning noncompliance by a hospital with the requirements of subs. (2) and (3)
20and shall periodically review hospital procedures to determine if a hospital is in
21compliance with the requirements.
AB1-SSA1-SA2, s. 148g 22Section 148g. 50.38 (1) of the statutes is renumbered 50.38 (1) (a).
AB1-SSA1-SA2, s. 148i 23Section 148i. 50.38 (1) (b) of the statutes is created to read:
AB1-SSA1-SA2,199,324 50.38 (1) (b) Whoever violates a requirement under s. 50.375 (2) or (3) may be
25required to forfeit not less than $2,500 nor more than $5,000 for each violation. If

1a hospital violates s. 50.375 (2) twice, the department may, after providing notice to
2the hospital, suspend or revoke the hospital's certificate of approval and may deny
3application for a new certificate of approval.
AB1-SSA1-SA2, s. 148j 4Section 148j. 50.38 (2) of the statutes is amended to read:
AB1-SSA1-SA2,199,105 50.38 (2) The department may directly assess forfeitures provided for under
6sub. (1) (a) or (b). If the department determines that a forfeiture should be assessed
7for a particular violation, the department shall send a notice of assessment to the
8hospital. The notice shall specify the amount of the forfeiture assessed, the violation
9and the statute or rule alleged to have been violated, and shall inform the hospital
10of the right to a hearing under sub. (3).".
AB1-SSA1-SA2,199,11 11162. Page 47, line 25: after that line insert:
AB1-SSA1-SA2,199,12 12" Section 148g. 50.35 of the statutes is amended to read:
AB1-SSA1-SA2,200,7 1350.35 Application and approval. Application for approval to maintain a
14hospital shall be made to the department on forms provided by the department. On
15receipt of an application, the department shall, except as provided in this section and
16s. 50.498, issue a certificate of approval if the applicant and hospital facilities meet
17the requirements established by the department. Except as provided in s. 50.498,
18this approval shall be in effect until, for just cause and in the manner herein
19prescribed, it is suspended or revoked. The certificate of approval may be issued only
20for the premises and persons or governmental unit named in the application and is
21not transferable or assignable. The department shall withhold, suspend or revoke
22approval for a violation of s. 150.935 (2) or a failure to comply with s. 150.935 (3) or
23165.40 (6) (a) 1. or 2. or 2001 Wisconsin Act .... (this act), section 9123 (5qr), but,
24except as provided in s. 50.498, otherwise may not withhold, suspend or revoke

1approval unless for a substantial failure to comply with ss. 50.32 to 50.39 or the rules
2and standards adopted by the department after giving a reasonable notice, a fair
3hearing and a reasonable opportunity to comply. Failure by a hospital to comply with
4s. 50.36 (3m) shall be considered to be a substantial failure to comply under this
5section. After the effective date of this section .... [revisor inserts date], the
6department may not issue an initial certificate of approval except for a critical access
7hospital that is converted from a previously-approved hospital.
".
AB1-SSA1-SA2, s. 148h 8Section 148h. 50.35 of the statutes, as affected by 2001 Wisconsin Act .... (this
9act), is amended to read:
AB1-SSA1-SA2,201,3 1050.35 Application and approval. Application for approval to maintain a
11hospital shall be made to the department on forms provided by the department. On
12receipt of an application, the department shall, except as provided in this section and
13s. 50.498, issue a certificate of approval if the applicant and hospital facilities meet
14the requirements established by the department. Except as provided in s. 50.498,
15this approval shall be in effect until, for just cause and in the manner herein
16prescribed, it is suspended or revoked. The certificate of approval may be issued only
17for the premises and persons or governmental unit named in the application and is
18not transferable or assignable. The department shall withhold, suspend or revoke
19approval for a violation of s. 150.935 (2) or a failure to comply with s. 150.935 (3) or
20165.40 (6) (a) 1. or 2. or 2001 Wisconsin Act .... (this act), section 9123 (5qr), but,
21except as provided in s. 50.498, otherwise may not withhold, suspend or revoke
22approval unless for a substantial failure to comply with ss. 50.32 to 50.39 or the rules
23and standards adopted by the department after giving a reasonable notice, a fair
24hearing and a reasonable opportunity to comply. Failure by a hospital to comply with
25s. 50.36 (3m) shall be considered to be a substantial failure to comply under this

1section. After the effective date of this section .... [revisor inserts date], the
2department may not issue an initial certificate of approval except for a critical access
3hospital that is converted from a previously-approved hospital.".
AB1-SSA1-SA2,201,4 4163. Page 48, line 5: after that line insert:
AB1-SSA1-SA2,201,6 5" Section 149g. 51.30 (4) (b) 13. of the statutes is renumbered 51.30 (4) (cm)
6and amended to read:
AB1-SSA1-SA2,201,207 51.30 (4) (cm) Required access to records. To the parents, children
8Notwithstanding par. (a), treatment records of an individual shall be released
9without informed written consent, except as restricted under par. (c), to the parent,
10child, sibling,
or spouse of an individual who is or was a patient at an inpatient
11facility,; to a law enforcement officer who is seeking to determine whether an
12individual is on unauthorized absence from the facility, ; and to mental health
13professionals who are providing treatment to the individual at the time that the
14information is released to others. Information released under this subdivision
15paragraph is limited to notice as to whether or not an individual is a patient at the
16inpatient facility and, if the individual is no longer a patient at the inpatient facility,
17the facility or other place, if known, at which the individual is located. This
18paragraph does not apply to an individual's parent, child, sibling, or spouse from
19whom the individual has specifically requested that the information under this
20paragraph be withheld
.".
AB1-SSA1-SA2,201,21 21164. Page 48, line 10: after that line insert:
AB1-SSA1-SA2,201,22 22" Section 150tg. 62.13 (5) (i) of the statutes is amended to read:
AB1-SSA1-SA2,203,223 62.13 (5) (i) Any person suspended, reduced, suspended and reduced, or
24removed by the board may appeal from the order of the board to the circuit court by

1serving written notice of the appeal on the secretary of the board within 10 days after
2the order is filed. Within 5 days after receiving written notice of the appeal, the board
3shall certify to the clerk of the circuit court the record of the proceedings, including
4all documents, testimony, and minutes. The action shall then be at issue and shall
5have precedence over any other cause of a different nature pending in the court,
6which shall always be open to the trial thereof. The court shall upon application of
7the accused or of the board fix a date of trial, which shall not be later than 15 days
8after such application except by agreement. The trial shall be by the court and upon
9the return of the board, except that the court may require further return or the taking
10and return of further evidence by the board. The question to be determined by the
11court shall be: Upon the evidence is there just cause, as described under par. (em),
12to sustain the charges against the accused? No costs shall be allowed either party
13and the clerk's fees shall be paid by the city. If the order of the board is reversed, the
14accused shall be forthwith reinstated and entitled to pay as though in continuous
15service. If the order of the board is sustained, it shall be final and conclusive. This
16paragraph does not apply to any person who is suspended, reduced, suspended and
17reduced, or removed by the board or by a committee or person acting under this
18subsection in place of a board, and who is subject to the terms of a collective
19bargaining agreement entered into under subch. IV of ch. 111 that provides an
20alternative to the appeals procedure specified in this paragraph, unless the person
21chooses to appeal the order to circuit court. If the alternative to the appeals
22procedure includes a hearing, the hearing shall be open to the public with reasonable
23advance notice given by the employer. An accused person who chooses to appeal the
24decision of the board through a collectively bargained alternative to the appeals

1procedure specified in this paragraph is considered to have waived his or her right
2to circuit court review of the board decision.
".
AB1-SSA1-SA2,203,3 3165. Page 48, line 10: after that line insert:
AB1-SSA1-SA2,203,4 4" Section 150rm. 66.0137 (4) of the statutes is amended to read:
AB1-SSA1-SA2,203,105 66.0137 (4) Self-insured health plans. If a city, including a 1st class city, or
6a village provides health care benefits under its home rule power, or if a town
7provides health care benefits, to its officers and employees on a self-insured basis,
8the self-insured plan shall comply with ss. 49.493 (3) (d), 631.89, 631.90, 631.93 (2),
9632.746 (10) (a) 2. and (b) 2., 632.747 (3), 632.85, 632.853, 632.855, 632.87 (4) and (5),
10632.89, 632.895 (9) to (14) (15), 632.896, and 767.25 (4m) (d).".
AB1-SSA1-SA2,203,11 11166. Page 48, line 10: after that line insert:
AB1-SSA1-SA2,203,13 12" Section 250b. 59.43 (1) (L) of the statutes, as affected by 2001 Wisconsin Act
1310
, is amended to read:
Loading...
Loading...